Kidney transplants from HIV positive donors to HIV recipients
17 October 2024. Related: Coinfections and complications, Cancer and HIV.
Cancer and HIV
AIDS 2024: Including people living with HIV in non-HIV research
11 September 2024. Related: Conference reports, Treatment access, Cancer and HIV, Treatment advocacy.
Anal cancer: 1 in 5 risk of missing precancerous lesions if only HSIL are biopsied
1 August 2023. Related: Conference reports, Cancer and HIV.
New UK vaccine schedule for HPV depends on HIV status
1 August 2023. Related: Guidelines, Coinfections and complications, Cancer and HIV.
Microbiota biomarkers might predict risk of HSIL progression: succinyl-CoA and cobalamin
1 June 2023. Related: Conference reports, Cancer and HIV.
Full results from ANCHOR study published in NEJM
1 July 2022. Related: Cancer and HIV.
CROI 2022: ANCHOR study reduces anal cancer by 57% and supports screening for people living with HIV
1 March 2022. Related: Conference reports, Cancer and HIV.
CROI 2022: Other studies on anal cancer
1 March 2022. Related: Conference reports, Cancer and HIV.
Early treatment prevents anal cancer in people living with HIV: ANCHOR study stops early
31 October 2021. Related: Cancer and HIV.
High efficacy of HPV vaccine in HIV positive gay men
1 June 2021. Related: Coinfections and complications, Cancer and HIV.
HPV vaccine does not prevent short-term recurrence of high grade lesions in HIV positive gay men
1 June 2021. Related: Coinfections and complications, Cancer and HIV.
Vaping can help HIV positive smokers who are not motivated to quit cigarettes
15 November 2019. Related: Conference reports, Coinfections and complications, Cancer and HIV, Ageing and life expectancy.
High acceptability of annual digital (finger) exam for early detection of anal cancer in gay men >35 years old
24 August 2018. Related: Conference reports, Coinfections and complications, Cancer and HIV.
High rates of anal HPV infection in gay men using PrEP in IPERGAY: the role of vaccination
24 August 2018. Related: Conference reports, Cancer and HIV, HIV prevention and transmission.
Statin use might reduce risk of cancer in HIV positive people
30 March 2018. Related: Conference reports, Cancer and HIV.
Report from the IAS HIV Cure & Cancer Forum, 22–23 July 2017, Paris
1 October 2017. Related: Conference reports, Cancer and HIV, Cure-related research.
Poppers and cancer risk in HIV negative and HIV positive gay men
26 June 2017. Related: Coinfections and complications, Cancer and HIV.
Anal cancer and HPV screening in HIV positive people
1 June 2016. Related: Conference reports, Cancer and HIV, Vaccines and microbicides.
UK guidelines for HIV-related cancers (2014): published online
24 March 2014. Related: Guidelines, Cancer and HIV.
Promising outcomes from laser ablative treatment of AIN2/3 to prevent anal cancer
1 June 2012. Related: Conference reports, Coinfections and complications, Cancer and HIV.
T-cell senescence linked to KS in peoplewith good HIV control
1 December 2010. Related: Conference reports, Cancer and HIV, Basic science and immunology.
HPV-based screen-and-treat is effective for cervical cancer prevention in HIV-positive women
1 October 2010. Related: Women's health, Cancer and HIV.
Clinical benefits of stopping smoking: CVD and CHD risk returns to that of previous smoker in HIV-positive people within three years
2 April 2010. Related: Conference reports, Lipodystrophy and metabolic complications, Cancer and HIV.
HIV increases the risk of lung cancer, independent of smoking status
2 April 2010. Related: Conference reports, Cancer and HIV.
Screening for anal cancer recommended for HIV positive men
21 February 2010. Related: Conference reports, Cancer and HIV.
Outcomes from screening study for anal cancer in HIV positive compared to HIV negative patients
10 February 2010. Related: Cancer and HIV.
Higher rates of non-AIDS cancers in HIV positive people
26 April 2009. Related: Conference reports, Cancer and HIV.
EMEA supports extension of D:A:D study until at least 2012 and the new remit to include non-AIDS cancers and kidney disease
9 February 2009. Related: Antiretrovirals, Cancer and HIV.
Risk factors for AIDS-defining and non AIDS-defining cancers
1 April 2008. Related: Conference reports, Cancer and HIV.
Increased anal HPV levels in HV-positive smokers
4 April 2007. Related: Conference reports, Cancer and HIV.
Limited impact of immunosuppression and HAART on the incidence of cervical squamous intraepithelial lesions in HIV positive women
5 February 2007. Related: Women's health, Cancer and HIV.
Elevated risk of lung cancer among people with AIDS
5 February 2007. Related: Coinfections and complications, Cancer and HIV.
Prevalence and predictors of squamous intraepithelial lesions of the cervix in HIV positive women in Lusaka, Zambia
7 October 2006. Related: Conference reports, Women's health, Cancer and HIV.
French study raises importance of early screening for anal cancer in HIV-positive people
9 September 2006. Related: Conference reports, Coinfections and complications, Cancer and HIV.
Tenofovir did not increase the incidence nephrotoxicity in limited numbers of HIV-positive patients using chemotherapy or HCV-coinfeced patients using ribavirin
9 September 2006. Related: Conference reports, Side effects, Cancer and HIV.
Clinical features and predictors of survival in patients with AIDS-related non-Hodgkin’s lymphoma
6 November 2004. Related: Coinfections and complications, Cancer and HIV.
Surgery and HAART are an effective combination for treating HPV-associated lesions
2 May 2004. Related: Cancer and HIV.
Increase of non-AIDS defining cancers in HOPS cohort
2 April 2004. Related: Conference reports, Cancer and HIV.
Stem-cell transplants help beat lymphoma
3 February 2004. Related: Coinfections and complications, Cancer and HIV.
Rituximab plus CDE for HIV-related Non-Hodgkins Lymphoma (NHL)
1 December 2003. Related: Conference reports, Antiretrovirals, Cancer and HIV.
Is stress associated with CIN progression in HIV-positive women?
1 July 2003. Related: Women's health, Cancer and HIV.
EBV levels in HIV-positive patients are not reduced by HAART
1 July 2003. Related: Coinfections and complications, Cancer and HIV.
Risk factors for paediatric HIV malignancies
1 July 2003. Related: Paediatric care, Cancer and HIV.
Conference has strong emphasis on women
1 April 2003. Related: Conference reports, Women's health, Lipodystrophy and metabolic complications, Cancer and HIV.
Rituximab and chemotherapy is highly effective in patients with CD20-positive non-Hodgkin’s lymphoma and HIV
1 March 2003. Related: Cancer and HIV.
Lung cancer in HIV positive HAART-users
1 March 2003. Related: Cancer and HIV.
HAART enhances regression of cervical intraepithelial neoplasia in HIV-seropositive women
13 November 2002. Related: Women's health, Cancer and HIV.
St John’s Wort interferes with chemotherapy, study shows
13 October 2002. Related: PK and drug interactions, Cancer and HIV.
HIV-associated malignancies in the HAART era: flickers of hope and understanding
11 September 2002. Related: Conference reports, Cancer and HIV.
Paclitaxel effective for advanced AIDS-related Kaposi Sarcoma
11 September 2002. Related: Coinfections and complications, Cancer and HIV.
HAART has little effect on anal cancer precursor lesions or on HPV
10 January 2002. Related: Cancer and HIV.
AIDS increases risk of non-AIDS-related cancers
1 October 2001. Related: Cancer and HIV.
Can low-dose shark cartilage shrink KS?
1 October 2001. Related: Coinfections and complications, Cancer and HIV.
HIV-positive women at high risk for pre-cancerous anal lesions
30 July 2001. Related: Women's health, Cancer and HIV.
Incidence of invasive cervical cancer in a cohort of HIV-infected women before and after the introduction of HAART
30 June 2001. Related: Women's health, Cancer and HIV.
Cancer risk increased with AIDS
17 May 2001. Related: Coinfections and complications, Cancer and HIV.
HIV status predicts anal dysphasia and carcinoma risk in HPV-infected individuals
17 May 2001. Related: Cancer and HIV.
Anal neoplasia grade linked with genetic changes
17 May 2001. Related: Cancer and HIV.
Spontaneous regression of CIN and delayed-type hypersensitivity to HPV-16 oncoprotein E7
17 January 2001. Related: Cancer and HIV.
Will cidofovir be useful against cervical lesions?
17 January 2001. Related: Cancer and HIV.
Human papillomavirus (HPV) may speed HIV progression
17 January 2001. Related: Women's health, Cancer and HIV.
High cancer incidence in perinatally HIV-infected children
17 January 2001. Related: Paediatric care, Cancer and HIV.